Table I Index
Table of Contents
|
Table I - 55 Morgan Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 278 | 410.7 | 148 | 495.1 | 130 | 347.8 |
| Oral cavity and pharynx | 6 | 8.7** | * | # | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 55 | 80.1 | 25 | 84.9 | 30 | 73.3 |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 24 | 33.4 | 8 | 26.4** | 16 | 37.3** |
| Rectum and rectosigmoid | 12 | 16.8** | 6 | 20.6** | 6 | 12.0** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 12 | 19.7** | 7 | 23.8** | 5 | 17.1** |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 54 | 82.1 | 37 | 123.7 | 17 | 50.0** |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 52 | 78.8 | 35 | 116.7 | 17 | 50.0** |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 6 | 7.4** | * | # | * | # |
| Melanoma of the skin | 6 | 7.4** | * | # | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 41 | 59.7 | * | # | 41 | 112.1 |
| Female genital system | 12 | 17.3** | -- | -- | 12 | 33.1** |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | 6 | 9.0** | -- | -- | 6 | 17.2** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | * | # | -- | -- | * | # |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 40 | 63.9 | 40 | 139.5 | -- | -- |
| Prostate gland | 40 | 63.9 | 40 | 139.5 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 21 | 30.5 | 15 | 50.7** | 6 | 17.1** |
| Urinary bladder | 9 | 12.6** | 8 | 28.6** | * | # |
| Kidney and renal pelvis | 12 | 17.9** | 7 | 22.1** | 5 | 14.4** |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 5 | 7.0** | * | # | * | # |
| Brain | 5 | 7.0** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 7 | 10.2** | * | # | * | # |
| Thyroid gland | 6 | 8.8** | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 11 | 15.3** | 5 | 12.8** | 6 | 17.0** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 9 | 12.0** | * | # | 5 | 12.6** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 7 | 9.8** | * | # | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 7 | 10.7** | 5 | 17.1** | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||